201. Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties.
- Author
-
Tang Y, Wang X, Li Z, He Z, Yang X, Cheng X, Peng Y, Xue Q, Bai Y, Zhang R, Zhao K, Liang F, Xiao X, Andersson U, Wang H, Billiar TR, and Lu B
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Caspases genetics, Cell Line, Female, Glucuronidase genetics, Glucuronidase metabolism, Glycocalyx metabolism, HMGB1 Protein metabolism, Humans, Immunomodulation, Lipopolysaccharides metabolism, Male, Mice, Mice, Knockout, Middle Aged, Sepsis mortality, Survival Analysis, Young Adult, Anticoagulants therapeutic use, Caspases metabolism, Heparin therapeutic use, Macrophages immunology, Sepsis drug therapy
- Abstract
Heparin, a mammalian polysaccharide, is a widely used anticoagulant medicine to treat thrombotic disorders. It is also known to improve outcomes in sepsis, a leading cause of mortality resulted from infection-induced immune dysfunction. Whereas it is relatively clear how heparin exerts its anticoagulant effect, the immunomodulatory mechanisms enabled by heparin remain enigmatic. Here, we show that heparin prevented caspase-11-dependent immune responses and lethality in sepsis independent of its anticoagulant properties. Heparin or a chemically modified form of heparin without anticoagulant function inhibited the alarmin HMGB1-lipopolysaccharide (LPS) interaction and prevented the macrophage glycocalyx degradation by heparanase. These events blocked the cytosolic delivery of LPS in macrophages and the activation of caspase-11, a cytosolic LPS receptor that mediates lethality in sepsis. Survival was higher in septic patients treated with heparin than those without heparin treatment. The identification of this previously unrecognized heparin function establishes a link between innate immune responses and coagulation., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF